CUV
CLINUVEL FPO [CUV]
Healthcare · ASX Small Cap
$10.0300 +0.2%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +15First seen: 2026-02-25
Score Breakdown
Technical48
Catalyst57
Sentiment50
Fundamental92
Momentum56
Risk Gate40
Active Signals
Bullish Signals
- RSI approaching oversold
- Stochastic oversold
- Price at lower Bollinger Band (oversold)
- Above-average volume (1.7x) on up day
- Near support level (potential bounce)
- Sharp 5-day decline (-10.6%)
- Cash positive / operating cashflow positive
- Moderate P/S ratio (5.3x)
- Moderate revenue growth (+7%)
- Piotroski F-Score strong (8/9)
- EPS estimates revised upward (+10pts)
- Near 52-week low (14% of range)
- Elevated short interest (7.2%)
- CANSLIM A: Moderate annual earnings growth (20%)
- Healthy profit margins (38%)
- Earnings momentum: 3 consecutive improvements
- Analyst EPS expectations rising (+22%)
- Days to cover very high (27.4)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: PHASE3 (est. 2010-12-09)
Risk Signals
- MACD momentum weakening
- Price below MAs (downtrend)
- Below 200-day MA (long-term downtrend)
- Earnings declining (-10% QoQ)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Half Year Results Presentation
NONE Appendix 4D and Half Year Report
NONE CLINUVEL Investor Webinar
HIGH CLINUVEL Record Revenues, Advances Strategic Expansion
Recent ASX Announcements
| 2026-02-25 | Half Year Results Presentation PRICE SENSITIVE |
| 2026-02-25 | CLINUVEL Record Revenues, Advances Strategic Expansion PRICE SENSITIVE |
| 2026-02-25 | Appendix 4D and Half Year Report PRICE SENSITIVE |
| 2026-02-18 | CLINUVEL Investor Webinar |
| 2026-02-01 | Clinical & Financial Update |
Key Metrics
$503.5M
Market Cap
132K
Avg Volume
1.7x
Vol Ratio
$9.41 — $14.00
52-Week Range
7.2%
Short Interest
N/A
Cash Runway
16.3%
ROE
38.1%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | declining | EPS Growth: -10% |
| A | Annual Earnings | weak | CAGR: 20% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 83% |
| L | Leader vs Laggard | laggard | RS: -4 |
| I | Institutional Sponsorship | weak | Inst: 9% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #2 of 119 · Sector avg: 51
View all Healthcare signals →